IQVIA Holdings Inc
IQV: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| bVd | LOCK|@$$^ | LOCK|v%j$D? |
Positive Outlook for Narrow-Moat Iqvia Supported by Durable Demand, AI Innovation, and Execution
Business Strategy and Outlook
Iqvia (formerly QuintilesIMS) is the result of the merger of Quintiles, a leading late-stage contract research organization, and IMS Health, a dominant player in life sciences data and analytics. The combined company has become a leader among contract research organizations, or CROs, and in the life sciences data and analytics industry. As a result of the merger, the company leads in real-world evidence, in which data from sources such as patient records or medical claims can be used to create clinical evidence for regulatory approval.
